V015-6033 Screening compound: benzyl N-{4-[2-(2-methoxyphenyl)ethyl]-2-methyl-3-oxo-2,3,4,5-tetrahydro-1,4-benzoxazepin-7-yl}carbamate

V015-6033 Screening compound: benzyl N-{4-[2-(2-methoxyphenyl)ethyl]-2-methyl-3-oxo-2,3,4,5-tetrahydro-1,4-benzoxazepin-7-yl}carbamate
V015-6033 Screening compound: benzyl N-{4-[2-(2-methoxyphenyl)ethyl]-2-methyl-3-oxo-2,3,4,5-tetrahydro-1,4-benzoxazepin-7-yl}carbamate alternative view

Chemical Structure Depiction of ChemDiv screening compound V015-6033
benzyl N-{4-[2-(2-methoxyphenyl)ethyl]-2-methyl-3-oxo-2,3,4,5-tetrahydro-1,4-benzoxazepin-7-yl}carbamate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V015-6033

Molecular Formula

C27H28N2O5 (C27 H28 N2 O5)

Compound Name

benzyl N-{4-[2-(2-methoxyphenyl)ethyl]-2-methyl-3-oxo-2,3,4,5-tetrahydro-1,4-benzoxazepin-7-yl}carbamate

IUPAC name

benzyl N-{4-[2-(2-methoxyphenyl)ethyl]-2-methyl-3-oxo-2345-tetrahydro-14-benzoxazepin-7-yl}carbamate

SMILES

CC(C(N(CCc(cccc1)c1OC)C1)=O)Oc(cc2)c1cc2NC(OCc1ccccc1)=O

InChI

InChI=1S/C27H28N2O5/c1-19-26(30)29(15-14-21-10-6-7-11-24(21)32-2)17-22-16-23(12-13-25(22)34-19)28-27(31)33-18-20-8-4-3-5-9-20/h3-13,16,19H,14-15,17-18H2,1-2H3,(H,28,31)/t19-/m0/s1

InChI Key

URNKPHSJQRPPES-IBGZPJMESA-N

MDL Number (MFCD)

MFCD19849513

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

460.53

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.938

Distribution Coefficient, logD

4.938

Water Solubility, LogSw

-4.84

Polar Surface Area

63.737

Acid Dissociation Constant (pKa)

11.73

Base Dissociation Constant (pKb)

2.34

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

25.90

V015-6033 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

PI3K-Targeted Library (17255 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases
  • Kinases

References: we are preparing a list of scientific research reports with V015-6033 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V015-6033?
Check Price and Availability of V015-6033, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V015-6033 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V015-6033
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V015-6033
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V015-6033 available by request